Modulation of Gut Microbiota: A Novel Paradigm of Enhancing the Efficacy of Programmed Death-1 and Programmed Death Ligand-1 Blockade Therapy

Blockade of programmed death 1 (PD-1) protein and its ligand programmed death ligand 1 (PD-L1) has been used as cancer immunotherapy in recent years, with the blockade of PD-1 being more widely used than blockade of PD-L1. PD-1 and PD-L1 blockade therapy showed benefits in patients with various type...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Yiming, Ma, Rena, Liu, Fang, Lee, Seul A., Zhang, Li
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2018
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5845387/
https://www.ncbi.nlm.nih.gov/pubmed/29556232
http://dx.doi.org/10.3389/fimmu.2018.00374

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5845387/
https://www.ncbi.nlm.nih.gov/pubmed/29556232
http://dx.doi.org/10.3389/fimmu.2018.00374

Ejemplares similares